A partir de cette page vous pouvez :
|Retourner au premier écran avec les dernières notices...||Votre compte|
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Vol.29, n°2 - April-June 2010 - Special Issue: Women, children and addiction (Bulletin de Journal of Addictive Diseases)
[n° ou bulletin]
est un bulletin de Journal of Addictive Diseases
Titre : Vol.29, n°2 - April-June 2010 - Special Issue: Women, children and addiction Type de document : Périodique Année de publication : 2010 Langues : Anglais Mots-clés : Thésaurus TOXIBASE
SEXE FEMININ ; DIFFERENCE DE GENRE ; ENFANT D'USAGER ; GROSSESSE ; ETHIQUE ; BUPRENORPHINE ; VIH
Domaine : Plusieurs produits / Several products Note de contenu : CONTENTS:
- Introduction to Women, Children and Addiction, Finnegan L. P., p. 113-116.
- Women and Drug Addiction: A Historical Perspective, Kandall S. R., p. 117-126.
- Women and Addiction: The Importance of Gender Issues in Substance Abuse Research, Tuchman E., p. 127-138.
- Substance Use and Women's Health, Kay A., Taylor T. E., Barthwell A. G., Wichelecki J., Leopold V., p. 139-163.
- Ethical Issues and Addiction, Lambert B., Scheiner M., Campbell D., p. 164-174.
- Addiction in Pregnancy, Keegan J., Parva M., Finnegan M., Gerson A., Belden M., p. 175-191.
- Human Immunodeficiency Virus Risk Behavior Among Female Substance Abusers, Ramsey S. E., Bell K. M., Engler P. A., p. 192-199.
- Pharmacotherapy in the Treatment of Addiction: Methadone, Kreek M. J., Borg L., Ducat E., Ray B., p. 200-216.
- Gender Issues in the Pharmacotherapy of Opioid-Addicted Women: Buprenorphine, Unger A., Jung E., Winklbaur B., Fischer G., p. 217-230.
- Punishing Pregnant Drug-Using Women: Defying Law, Medicine, and Common Sense, Flavin J., Paltrow L. M., p. 231-244.
- Prenatal Drug Exposure: Infant and Toddler Outcomes, Bandstra E. S., Morrow C. E., Mansoor E., Accornero V. H., p. 245-258.
- Children of Addicted Women, Lester B. M., Lagasse L. L., p. 259-276.
Lien : http://www.informaworld.com/smpp/title~db=all~content=g921472153 Permalink : http://bdoc.ofdt.fr/index.php?lvl=bulletin_display&id=1716[n° ou bulletin]Whether men or women are responsible for the size of gender gap in alcohol consumption depends on alcohol measure: A study across the United States / S. C. M. ROBERTS in Contemporary Drug Problems, Vol.39, n°2 (Summer 2012)
in Contemporary Drug Problems > Vol.39, n°2 (Summer 2012) . - 195-212
Titre : Whether men or women are responsible for the size of gender gap in alcohol consumption depends on alcohol measure: A study across the United States Type de document : Périodique Auteurs : S. C. M. ROBERTS Année de publication : 2012 Article en page(s) : 195-212 Langues : Anglais Mots-clés : Thésaurus Géographique
ALCOOL ; DIFFERENCE DE GENRE ; CONSOMMATION ; EPIDEMIOLOGIE DESCRIPTIVE
Discipline : EPI Epidémiologie / Epidemiology Domaine : Alcool / Alcohol Résumé : Smaller gender differences in alcohol consumption are often interpreted to mean something about women's drinking, for example, that women are increasing consumption to men's levels. However, prior research is unclear. This study sought to determine whether variation in size of gender differences in alcohol consumption across the United States was due to male or female consumption. Data from the 2005 Behavioral Risk Factor Surveillance System were used to test the hypothesis that variation in size of gender differences would be associated with women's, but not men's, consumption. Pearson's correlations examined associations between gender-specific values of, and gender differences in, consumption in each state. The size of gender difference was associated with proportion of female, but not male, drinkers. Conversely, size of gender difference was associated with male frequency, five-plus frequency, volume, and risky drinking, but not female frequency, five-plus frequency, volume, or risky drinking. These findings suggest that smaller gender differences in cross-sectional studies cannot be interpreted as due to women's alcohol consumption. Affiliation : Advancing New Standards in Reproductive Health (ANSIRH), University of California, San Francisco, USA Cote : Abonnement Lien : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522467/ Permalink : http://bdoc.ofdt.fr/index.php?lvl=notice_display&id=70453[article]Why we should consider sex (and study sex differences) in addiction research / C. SANCHIS-SEGURA ; J. B. BECKER in Addiction Biology, Vol.21, n°5 (September 2016)
in Addiction Biology > Vol.21, n°5 (September 2016) . - 995-1006
Titre : Why we should consider sex (and study sex differences) in addiction research Type de document : Périodique Auteurs : C. SANCHIS-SEGURA ; J. B. BECKER Année de publication : 2016 Article en page(s) : 995-1006 Langues : Anglais Mots-clés : Thésaurus TOXIBASE
DIFFERENCE DE GENRE ; PHYSIOLOGIE ; GENETIQUE ; ABUS ; ADDICTION ; NEUROBIOLOGIE ; ENDOCRINOLOGIE
Discipline : PRO Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods Domaine : Plusieurs produits / Several products Résumé : Among mammals, every cell has a biological sex, and the sex of an individual pervades its body and brain. In this review, we describe the processes through which mammals become phenotypically male or female by organizational and activational influences of genes and hormones throughout development. We emphasized that the molecular and cellular changes triggered by sex chromosomes and steroid hormones may generate sex differences in overt physiological functions and behavior, but they may alternatively promote end-point convergences between males and females. Clinical and pre-clinical evidences suggest that sex and gender differences modulate drug consumption as well as of the transition towards drug-promoted pathological states such as dependence and addiction. Additionally, sex differences in drug pharmacokinetics and pharmacodynamics will also influence dependence and addiction as well as side effects of drugs. These effects will further interact with socially gendered factors to result in sex differences in the access to, engagement in and efficacy of any therapeutic attempt. Finally, we maintain that 'sex sameness' is as important as 'sex differences' when building a complete understanding of biology for both males and females and provide a framework with which to classify and guide investigation into the mechanisms mediating sex differences and sex sameness. Sous-type de document : Revue de la littérature / Literature review Affiliation : Departament de Psicologia básica, clínica i psicobiologia. Área de Psicobiología, Universitat Jaume I, Castellón de la Plana, Spain Lien : http://dx.doi.org/10.1111/adb.12382 Permalink : http://bdoc.ofdt.fr/index.php?lvl=notice_display&id=77915[article]Women and addiction: a trauma-informed approach / S. C. COVINGTON in Journal of Psychoactive Drugs, n°SARC Suppl.5 (2008)
in Journal of Psychoactive Drugs > n°SARC Suppl.5 (2008) . - 377-385
Titre : Women and addiction: a trauma-informed approach Type de document : Périodique Auteurs : S. C. COVINGTON Année de publication : 2008 Article en page(s) : 377-385 Note générale : Journal of Psychoactive Drugs, 2008, (SARC Suppl.5), 377-385 Langues : Anglais Mots-clés : Thésaurus TOXIBASE
SEXE FEMININ ; TRAITEMENT INTEGRE ; DIFFERENCE DE GENRE ; TRAITEMENT ; DEPENDANCE ; TRAUMATISME ; MODELE ; ABUS SEXUEL
Domaine : Plusieurs produits / Several products Résumé :
Historically, substance abuse treatment has developed as a single-focused intervention based on the needs of addicted men. Counselors focused only on the addiction and assumed that other issues would either resolve themselves through recovery or would be dealt with by another helping professional at a later time. However, treatment for womens addictions is apt to be ineffective unless it acknowledges the realities of womens lives, which include the high prevalence of violence and other types of abuse. A history of being abused increases the likelihood that a woman will abuse alcohol and other drugs. This article presents the definition of and principles for gender-responsive services and the Womens Integrated Treatment (WIT) model. This model is based on three foundational theories: relational-cultural theory, addiction theory, and trauma theory. It also recommends gender-responsive, trauma-informed curricula to use for womens and girls treatment services. (Author' s abstract)
Sous-type de document : N° spécial de revue / Special issue of a journal Affiliation : Etats-Unis. United States. Numéro Toxibase : 1302650 Centre Emetteur : 13 OFDT Cote : Abonnement Permalink : http://bdoc.ofdt.fr/index.php?lvl=notice_display&id=52017[article]Women and substance abuse problems / R. A. CORMIER ; C. A. DELL ; N. POOLE in BMC Women's Health, Vol.4, Suppl.1 (2004)
in BMC Women's Health > Vol.4, Suppl.1 (2004) . - S8 ; 10 p.
Titre : Women and substance abuse problems Type de document : Périodique Auteurs : R. A. CORMIER ; C. A. DELL ; N. POOLE Année de publication : 2004 Article en page(s) : S8 ; 10 p. Langues : Anglais Mots-clés : Thésaurus Géographique
SEXE FEMININ ; DIFFERENCE DE GENRE ; PREVALENCE ; MORBIDITE ; GROSSESSE ; ETUDE TRANSVERSALE ; ALCOOL ; PRODUIT ILLICITE ; MEDICAMENTS ; RECOMMANDATION
Discipline : EPI Epidémiologie / Epidemiology Domaine : Plusieurs produits / Several products Résumé : HEALTH ISSUES: Differences exist in the prevalence and physical health impacts of problem substance use among men and women. These differences are also found in the mental health and trauma events related to substance use, barriers to treatment and harm-reduction services and the impact of substance use on pregnancy and parenting. Data from the 2000-2001 Canadian Community Health Survey and Canada's Alcohol and Other Drugs Survey (1994) were used to explore this issue further.
KEY FINDINGS: While women use alcohol and illicit drugs at lower rates than men, the health impact of their use is significant, and in some cases greater than for men. Women are more likely to use prescribed psychoactive drugs (e.g. pain relievers, sleeping pills, tranquillizers) and most of these drugs have addictive potential and long-term negative consequences on health. Research collected from treatment centres in Canada show high rates of victimization experienced by women, which have implications for both their substance use treatment and improvement in mental health.
DATA GAPS AND RECOMMENDATIONS: Significant gaps exist in our knowledge on the level, type, and impact of substance use and the adequacy of programming for Canadian women. Information that might be used to guide prevention initiatives, such as the amount of alcohol that might safely be used in pregnancy and the incidence of fetal alcohol syndrome, related birth defects and developmental disabilities are unknown. Improved surveillance, sensitive and comprehensive screening for substance use problems, accessible treatment and harm reduction programming, and coordination with the mental health and violence fields are recommended.
Refs biblio. : 74 Affiliation : British Columbia Centre of Excellence for Women's Health, Vancouver, Canada Lien : http://dx.doi.org/10.1186/1472-6874-4-S1-S8 Permalink : http://bdoc.ofdt.fr/index.php?lvl=notice_display&id=71204[article]Women's gender performances and cultural heterogeneity in the illegal drug economy / H. GRUNDETJERN in Criminology, Vol.53, n°2 (May 2015)PermalinkWomen's health and well-being in Europe: beyond the mortality advantage / OMS / WHO Regional Office for EuropePermalinkWorking hours and alcohol problems in early adulthood / S. J. GIBB ; D. M. FERGUSSON ; L. J. HORWOOD in Addiction, Vol.107, n°1 (January 2012)Permalink